Steven Chamow, Ph.D.
About Steven Chamow, Ph.D.
Steven Chamow, Ph.D. - Vice President of Research and Development
Steven Chamow, Ph.D., serves as the Vice President of Research and Development. With over 25 years of experience in biopharmaceutical product development, Dr. Chamow has played a significant role in the advancement of multiple pharmaceutical products. His contributions have been integral in bringing innovative medicines to the market.
Steven Chamow Biopharmaceutical Product Development Experience
Steven Chamow, Ph.D., boasts over 25 years of experience in biopharmaceutical product development. He has played a pivotal role in the development of three marketed products: Avastin, Natrecor, and Vectibix. His extensive background in this field underscores his expertise and dedication to advancing biopharmaceutical therapies.
Steven Chamow Professional Leadership Roles
Throughout his career, Steven Chamow, Ph.D., has held several leadership positions in the biopharmaceutical industry. He has served at Intradigm, Genitope Corporation, and Abgenix, Inc. Earlier in his career, he was a senior scientist at Genentech, contributing significantly to the company's research initiatives.
Steven Chamow Scientific Publications and Patents
Steven Chamow is an accomplished author and co-author of more than 50 scientific publications and patents. His contributions to scientific literature and intellectual property in the field of biopharmaceuticals highlight his extensive research proficiency and thought leadership.
Steven Chamow Education and Scholarly Contributions
Steven Chamow earned his Ph.D. in biochemistry from the University of California, Davis. He has also co-edited two books focused on therapeutic antibody fusion proteins, further demonstrating his expertise and active participation in the scientific community.